The Lancet: OPTIMA-AF, Is 1 Month Enough After PCI? | JACC Baran
Hosts Mitsuaki Sawano, MD, Shun Kohsaka, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD, welcome Yohei Sotomi, MD, PhD (The University of Osaka), and Ken Kozuma, MD, PhD (Teikyo University) for a spe...
25 Elo 47min
HFpEF: Why Earlier May Be Better | JACC Baran
Hosts Mitsuaki Sawano, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD welcome Shunichi Doi, MD (St. Marianna University School of Medicine) to discuss his JACC: Heart Failure study, Heart Failure Dur...
18 Elo 38min
Post-PCI Hematoma: What IVUS Tells Us | JACC Baran
Percutaneous coronary intervention (PCI) is safer than ever, yet coronary hematoma remains an underrecognized cause of early ischemic complications. In this episode, Host Mitsuaki Sawano, MD welcome T...
11 Elo 35min
Pediatric Heart Transplantation: When Priority Doesn't Match Urgency | JACC Baran
Pediatric heart transplantation is one of medicine's scarcest resources, where every allocation decision can mean the difference between life and death. But does the current system truly prioritize th...
4 Elo 35min
PACs: Benign Bystanders or AF in Disguise? | JACC Baran
Premature atrial complexes (PACs) are among the most common arrhythmias encountered in daily practice and are often dismissed as benign. But are they truly harmless—or could some represent the earlies...
28 Heinä 35min
Cancer VTE + DOAC: Who Will Bleed? | JACC Baran
Patients with active cancer face a difficult balance: preventing recurrent venous thromboembolism while avoiding major bleeding during anticoagulation. But which patients are truly at highest bleeding...
21 Heinä 39min
HFpEF Without Obesity: What Coronary Microcirculation Tells Us | JACC Baran
Host Mitsuaki Sawano, MD, welcomes Kai Nogami, MD (Mayo Clinic), to discuss his JACC Brief Report, "Higher Prevalence of Coronary Microvascular Dysfunction in Patients With HFpEF Without Obesity." Why...
14 Heinä 37min
